| Financial Year |
March 31 2023 |
| Monetary Funds |
502,906,726.23 |
| Held-for-trading Financial Assets |
308,222,264.36 |
| Notes Receivable |
4,875,123.28 |
| Accounts Receivable |
322,991,813.49 |
| Advances to Suppliers |
20,347,060.29 |
| Other Receivables |
11,296,502.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
101,769,005.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,362,034.12 |
| Total Current Assets |
1,280,770,530.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
125,285,417.56 |
| Under-construction Projects |
428,803.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,099,985.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,663,634.65 |
| Deferred Income Tax Assets |
8,488,591.81 |
| Other Non-Current Assets |
1,312,492.76 |
| Sub-Total of Non-Current Assets |
227,120,183.37 |
| Total Assets |
1,507,890,713.94 |
| Short-Term Loans |
60,082,666.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,271,380.03 |
| Accounts Payable |
143,290,874.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,144,579.82 |
| Taxes Payable |
20,959,569.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,070,656.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,548,345.86 |
| Other Current Liabilities |
475,560.37 |
| Sub-Total of Current Liabilities |
312,013,780.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,283,333.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,884,404.81 |
| Total Liabilities |
351,898,184.91 |
| Paid-In Capital(Or Share Stock) |
95,805,000.00 |
| Capital Surplus |
580,300,187.26 |
| Surplus Reserve |
47,902,500.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
428,661,718.45 |
| Minority Stockholder's Interest |
2,405,532.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,153,586,996.90 |
| Owner's Equity（Stockholder's Equity） |
1,155,992,529.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,507,890,713.94 |
